SCHEMBL174137

SCHEMBL174137

Cc1csc2c(Nc3cc[nH]n3)nc(C(=O)c3ccc(F)cc3)nc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.45
NPSR1 Q6W5P4 1/20 0.45
AURKA O14965 3/20 0.39
AURKB Q96GD4 1/20 0.38
RXFP1 Q9HBX9 2/20 0.35
JAK2 O60674 1/20 0.35
JAK3 P52333 1/20 0.35
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 1/20 0.34
PRKCI P41743 5/20 0.33
GRM5 P41594 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
PTGS1 P23219 1/20 0.33
MAPK1 P28482 1/20 0.33
KDR P35968 1/20 0.33
F2 P00734 1/20 0.33
MAPT P10636 1/20 0.33
CSNK2A1 P68400 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL166590 0.86 AURKA (0.55) KDM4ENPSR1AURKAAURKBJAK2
SCHEMBL173921 0.86 AURKA (0.38) KDM4ENPSR1AURKAAURKBRXFP1
SCHEMBL174455 0.78 AURKA (0.42) KDM4EAURKAAURKBRXFP1KMT2A
SCHEMBL173813 0.78 JAK2 (0.46) KDM4ENPSR1RXFP1JAK2JAK3
SCHEMBL256527 0.78 JAK2 (0.46) KDM4ENPSR1RXFP1JAK2JAK3
SCHEMBL174933 0.77 AURKA (0.40) KDM4EAURKAAURKBRXFP1KMT2A
SCHEMBL174333 0.77 AURKA (0.47) AURKAAURKBRAB9AMAPT
SCHEMBL164030 0.76 KDM4E (0.50) KDM4ENPSR1RXFP1KMT2AMEN1
SCHEMBL174680 0.76 AURKA (0.58) KDM4ENPSR1AURKAAURKBJAK2
SCHEMBL173984 0.76 AURKA (0.47) AURKAAURKBRXFP1ADORA3PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611812-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2013-07-10 EP claimed
WO-2012030894-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 WO claimed
EP-2611812-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2013-07-10 EP disclosed
WO-2012030894-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 WO disclosed